Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012


#105439

99pages

GlobalData

$ 1000

In Stock



GlobalData's clinical trial report, Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Alcoholic Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Non-Alcoholic Steatohepatitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Non-Alcoholic Steatohepatitis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6

Introduction 7
Non-Alcoholic Steatohepatitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Non-Alcoholic Steatohepatitis 24
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Norgine Limited 31
Clinical Trial Overview of Norgine Limited 31
Galmed International Ltd. 32
Clinical Trial Overview of Galmed International Ltd. 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Raptor Pharmaceuticals Corp. 34
Clinical Trial Overview of Raptor Pharmaceuticals Corp. 34
CATALYSIS, S.L. 35
Clinical Trial Overview of CATALYSIS, S.L. 35
CROLLL GmbH 36
Clinical Trial Overview of CROLLL GmbH 36
Immuron Limited 37
Clinical Trial Overview of Immuron Limited 37
Zydus Cadila Healthcare Limited 38
Clinical Trial Overview of Zydus Cadila Healthcare Limited 38
NasVax Ltd. 39
Clinical Trial Overview of NasVax Ltd. 39
Rottapharm SpA 40
Clinical Trial Overview of Rottapharm SpA 40
Trophos SA 41
Clinical Trial Overview of Trophos SA 41
Phenex Pharmaceuticals AG 42
Clinical Trial Overview of Phenex Pharmaceuticals AG 42
Astellas Pharma Inc. 43
Clinical Trial Overview of Astellas Pharma Inc. 43
Mochida Pharmaceutical Co., Ltd. 44
Clinical Trial Overview of Mochida Pharmaceutical Co., Ltd. 44
Gilead Sciences, Inc. 45
Clinical Trial Overview of Gilead Sciences, Inc. 45
Clinical Trial Overview of Top Universities / Institutes / Hospitals 46
Yokohama City University 46
Clinical Trial Overview of Yokohama City University 46
The University of Texas Health Science Center at San Antonio 47
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 47
Mayo Clinic 48
Clinical Trial Overview of Mayo Clinic 48
Tehran University of Medical Sciences 49
Clinical Trial Overview of Tehran University of Medical Sciences 49
University of California, San Diego 50
Clinical Trial Overview of University of California, San Diego 50
Monash University 51
Clinical Trial Overview of Monash University 51
University of Illinois 52
Clinical Trial Overview of University of Illinois 52
University of California, Davis 53
Clinical Trial Overview of University of California, Davis 53
Yale University 54
Clinical Trial Overview of Yale University 54
Brooke Army Medical Center 55
Clinical Trial Overview of Brooke Army Medical Center 55
University of Virginia 56
Clinical Trial Overview of University of Virginia 56
University of Zurich 57
Clinical Trial Overview of University of Zurich 57
Medical College of Wisconsin 58
Clinical Trial Overview of Medical College of Wisconsin 58
Northwestern University 59
Clinical Trial Overview of Northwestern University 59
University of Colorado 60
Clinical Trial Overview of University of Colorado 60
Imperial College London 61
Clinical Trial Overview of Imperial College London 61
University Hospital, Angers 62
Clinical Trial Overview of University Hospital, Angers 62
University of Michigan 63
Clinical Trial Overview of University of Michigan 63
Case Western Reserve University 64
Clinical Trial Overview of Case Western Reserve University 64
Chinese University of Hong Kong 65
Clinical Trial Overview of Chinese University of Hong Kong 65
Five Key Clinical Profiles 66

Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99
 
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, G7 Countries, 2012* 17
Non-Alcoholic Steatohepatitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, E7 Countries, 2012* 19
Non-Alcoholic Steatohepatitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine Limited, 2012* 31
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2012* 32
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 33
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2012* 34
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2012* 35
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CROLLL GmbH, 2012* 36
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immuron Limited, 2012* 37
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2012* 38
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by NasVax Ltd., 2012* 39
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rottapharm SpA, 2012* 40
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Trophos SA, 2012* 41
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2012* 42
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 43
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mochida Pharmaceutical Co., Ltd., 2012* 44
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 45
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2012* 46
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2012* 47
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 48
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2012* 49
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012* 50
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Monash University, 2012* 51
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2012* 52
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2012* 53
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 54
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brooke Army Medical Center, 2012* 55
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2012* 56
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 57
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012* 58
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 59
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 60
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 61
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2012* 62
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012* 63
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2012* 64
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 65List of Figures

Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Non-Alcoholic Steatohepatitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
GlobalData Methodology 97